Stock Analiz

Kestra Medical Technologies, Ltd. (KMTS) stock forecast and price target

Price $28.64 · data as of November 13, 2026

12-month price target

Average target$31.12
Upside / downside+8.7%
Analysts8
ConsensusStrong buy
Low $28.00Average $31.12High $34.00

Gold marker: average target · white marker: today’s price ($28.64)

Analyst ratings

Strong buy 2Buy 6Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends April 30, 2027
$-2.45−43.4%$141M
Next fiscal year
ends April 30, 2028
$-2.06+16.1%$196M
Quarter after
ends January 31, 2027
$-0.57−42.3%$35M

Consensus of the analysts covering Kestra Medical Technologies, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.

Frequently asked questions

What is the Kestra Medical Technologies stock price target?

The average 12-month target from 8 analysts is $31.12, 8.7% above the current price of $28.64 Targets range from $28.00 to $34.00.

Is Kestra Medical Technologies a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 6 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Kestra Medical Technologies expected to earn?

Analysts expect EPS of $-2.45 for the fiscal year ending April 30, 2027 and $-2.06 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.